LOADING

Type to search

Dupilumab maintains its effectiveness up to five years in patients with eczema: Study – Medical Xpress

Tags:
Previous Article
Next Article

You Might also Like

Apex Dermatology physician assistant appointed to the American Academy of Physician Associates House of Delegates - The Morning Journal
Dupixent® (dupilumab) Late-Breaking Data at AAD Show Significant … – GlobeNewswire
eczemarelief March 18, 2023
Baricitinib Effective in Atopic Dermatitis Patients who Failed Dupilumab
Baricitinib Effective in Atopic Dermatitis Patients who Failed Dupilumab
eczemarelief September 29, 2022
Dupilumab Promising Long Term for Atopic Dermatitis in Adolescents
Dupilumab Promising Long Term for Atopic Dermatitis in Adolescents
eczemarelief July 11, 2022

Leave a Comment

Your email address will not be published. Required fields are marked *

Related Stories

Apex Dermatology physician assistant appointed to the American Academy of Physician Associates House of Delegates - The Morning Journal
Dupixent® (dupilumab) Late-Breaking Data at AAD Show Significant … – GlobeNewswire
Baricitinib Effective in Atopic Dermatitis Patients who Failed Dupilumab
Baricitinib Effective in Atopic Dermatitis Patients who Failed Dupilumab
Dupilumab Promising Long Term for Atopic Dermatitis in Adolescents
Dupilumab Promising Long Term for Atopic Dermatitis in Adolescents

Next Up

Olympian Suni Lee Shares 'Isolating’ Eczema Struggle: 'Daily Thing That I Have to Battle' – Yahoo Canada Shine On
eczemarelief August 15, 2024
Eczema-Relief.com ©All rights reserved.